Trials / Withdrawn
WithdrawnNCT04003519
Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
Non-interventional, Prospective Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to collect data about predictive factors for the efficacy of Lanreotide Autogel in patients with acromegaly in routine clinical practice.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2023-06-30
- Completion
- 2023-12-30
- First posted
- 2019-07-01
- Last updated
- 2020-06-02
Source: ClinicalTrials.gov record NCT04003519. Inclusion in this directory is not an endorsement.